Not applicableStudy completedNCT03801603What this trial is testingImproving HPV Vaccination Rates Among Rural and Native American AdolescentsWho this might be right forHPV Vaccinations University of California, Davis 263
Not applicableStudy completedNCT03726151What this trial is testingComparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCsWho this might be right forHuman Papillomavirus Infection University of California, Los Angeles 17,000
Post-approval studies (Phase 4)Study completedNCT01431079What this trial is testingA Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College MenWho this might be right forHPV Vaccine Acceptability University of Cincinnati 90
Not applicableUnknownNCT06405048What this trial is testingImpact of a Mock-up Fact-checking Extension on HPV Vaccine Misinformation: A Survey ExperimentWho this might be right forHPV Vaccine Fudan University 1,200
Not applicableActive Not RecruitingNCT01901770What this trial is testingThe Parents in Appalachia Receive Education Needed for Teen ProjectWho this might be right forHealthyHuman Papilloma Virus Infection Ohio State University Comprehensive Cancer Center 624
Large-scale testing (Phase 3)Study completedNCT01984697What this trial is testingA Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)Who this might be right forHuman Papillomavirus Infection Merck Sharp & Dohme LLC 1,518
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07756840What this trial is testingCombination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)Who this might be right forRespiratory Recurrent Papillomatosis (RRP)Human Papillomavirus (HPV)Papillomavirus Infection+3 more National Cancer Institute (NCI) 50
Not applicableStudy completedNCT05736718What this trial is testingEngaging Clinical Champions to Improve HPV VaccinationWho this might be right forHuman Papilloma Virus UNC Lineberger Comprehensive Cancer Center 47
Large-scale testing (Phase 3)Study completedNCT03525210What this trial is testingStudy of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised PatientsWho this might be right forHuman Papilloma VirusHivOrgan Transplants Universitaire Ziekenhuizen KU Leuven 271
Not applicableLooking for participantsNCT06831383What this trial is testingThe STOP-HPV Scale Up StudyWho this might be right forHuman Papilloma Virus Vaccine University of California, Los Angeles 100,000
Large-scale testing (Phase 3)Active Not RecruitingNCT06041061What this trial is testingEvaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 YearsWho this might be right forHPV InfectioNHPV-Related Carcinoma Sinocelltech Ltd. 18,000
Not applicableLooking for participantsNCT05336240What this trial is testingPCOM2 - The Physician Communication Intervention, Version 2.0Who this might be right forHPV InfectionPreventive Health Services University of Colorado, Denver 120
Not applicableStudy completedNCT03442062What this trial is testingQuality Improvement Strategies to Increase Human Papillomavirus (HPV) VaccinationWho this might be right forHuman Papillomavirus Infection University of North Carolina, Chapel Hill 264
Large-scale testing (Phase 3)UnknownNCT03296397What this trial is testingEfficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic ResponseWho this might be right forGenital Warts Assistance Publique - Hôpitaux de Paris 300
Testing effectiveness (Phase 2)Study completedNCT01928225What this trial is testingRandomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSILWho this might be right forCervical High Grade Squamous Intraepithelial Lesion University of Witwatersrand, South Africa 180
Early research (Phase 1)Study completedNCT04083196What this trial is testingA Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 YearsWho this might be right forHPV InfectionHPV-Related Cervical Carcinoma National Vaccine and Serum Institute, China 90
Large-scale testing (Phase 3)Study completedNCT00423046What this trial is testingImmunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of AgeWho this might be right forInfections, PapillomavirusPapillomavirus Vaccines GlaxoSmithKline 1,106
Large-scale testing (Phase 3)Study completedNCT00799825What this trial is testingSafety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the USWho this might be right forInfections, Papillomavirus GlaxoSmithKline 346
Not applicableActive Not RecruitingNCT06161831What this trial is testingHPV Vaccine Reminders - SEARCH II StudyWho this might be right forHuman Papillomavirus Vaccination Columbia University 396
Not applicableStudy completedNCT07200414What this trial is testingStrengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)Who this might be right forHuman Papillomavirus (HPV) VaccineHuman Papillomavirus (HPV) VaccinesHuman Papillomavirus (HPV) Infections+1 more Johns Hopkins Bloomberg School of Public Health 12,654